Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.

Last updated on 22-8-2019 by Anonymous (not verified)

Peer reviewed scientific article




Lan Xu



BACKGROUND: Cervical cancer screening programs are switching from cytology-based screening to high-risk (hr) HPV testing. Only clinically validated tests should be used in clinical practice. OBJECTIVES: To assess the clinical performance of the Roche Linear Array HPV genotyping test (Linear Array) within the VALGENT-3 framework. STUDY DESIGN: The VALGENT framework is designed for comprehensive comparison and clinical validation of HPV tests that have limited to extended genotyping capacity. The Linear Array enables type-specific detection of 37 HPV types. For the purpose of this study…

Associated health topics:

QR code

QR code for this page URL